Healthy potentially undervalued

Results

2408

Companies which are potentially undervalued and in an acceptable financial position.

2408 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	ACX	CA$6.55	8.4%	39.1%	CA$245.3m	CA$10.25	9.9	9.4%	0%	Energy
	IMG	CA$25.21	12.8%	127.1%	CA$14.4b	CA$32.17	8.9	7.6%	n/a	Materials
	SM	US$32.42	11.7%	19.9%	US$7.7b	US$39.27	7.7	21.1%	2.7%	Energy
	LKNC.Y	US$33.80	-7.9%	-13.3%	US$11.0b	US$48.21	19.4	23.3%	n/a	Consumer Services
	ACIW	US$52.75	-8.7%	11.5%	US$5.3b	US$67.33	23.6	16.0%	n/a	Software
	BZ	US$16.09	-0.6%	-28.3%	US$7.5b	US$20.83	14.4	6.4%	1.0%	Commercial Services
	TCL.A	CA$5.19	-2.1%	-73.7%	CA$447.1m	CA$7.17	2.8	-32.0%	3.9%	Materials
	SGRY	US$15.32	0%	-35.0%	US$1.9b	US$18.73	0.6	125.8%	n/a	Healthcare
	LKQ	US$24.71	2.5%	-22.1%	US$6.2b	US$32.50	13.5	16.5%	4.9%	Retail
	SSRM	CA$45.32	11.6%	101.2%	CA$9.1b	CA$56.91	11.7	17.1%	0.4%	Materials
	HITI	CA$3.25	2.4%	-3.6%	CA$287.3m	CA$7.30	0.4	63.2%	n/a	Pharmaceuticals & Biotech
	SLGN	US$40.67	-4.7%	-14.5%	US$4.4b	US$54.77	15.9	15.8%	2.1%	Materials
	SARO	US$27.39	-11.7%	-2.7%	US$9.3b	US$35.88	28.0	17.3%	n/a	Capital Goods
	HURN	US$150.31	0.4%	9.7%	US$2.4b	US$190.75	20.7	24.1%	n/a	Commercial Services
	TRLV	US$9.11	7.9%	1.2%	US$1.8b	US$18.18	1.5	124.9%	n/a	Pharmaceuticals & Biotech
	XP	US$15.44	-9.1%	-11.7%	US$8.0b	US$23.17	7.8	11.1%	1.3%	Diversified Financials
	PLOW	US$42.51	-6.8%	31.8%	US$979.4m	US$54.00	19.1	17.2%	2.8%	Capital Goods
	LMB	US$44.95	-9.6%	-59.2%	US$553.3m	US$78.20	17.7	21.0%	n/a	Capital Goods
	BLBD	US$64.33	-16.4%	13.9%	US$2.1b	US$89.13	7.2	-8.1%	n/a	Capital Goods
	TRU	US$79.44	-0.7%	-14.4%	US$15.4b	US$96.24	20.6	4.8%	0.6%	Commercial Services
	SLDE	US$20.96	1.1%	35.6%	US$2.4b	US$25.80	4.4	-12.6%	1.3%	Insurance
	ILPT	US$9.07	3.7%	54.0%	US$590.7m	US$11.17	1.3	20.7%	4.4%	Real Estate
	TCW	CA$6.26	3.3%	4.5%	CA$1.3b	CA$8.00	14.8	9.0%	3.5%	Energy
	AR	US$37.48	9.2%	15.8%	US$11.6b	US$49.35	10.6	5.6%	n/a	Energy

Page 1 of 67